These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7898066)

  • 1. Differential inhibition of platelet aggregation and calcium mobilization by nitroglycerin and stabilized nitric oxide.
    Amano M; Takahashi M; Kosaka T; Kinoshita M
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):860-6. PubMed ID: 7898066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet function is inhibited by nitric oxide liberation during nitroglycerin-induced hypotension anaesthesia.
    Aoki H; Inoue M; Mizobe T; Harada M; Imai H; Kobayashi A
    Br J Anaesth; 1997 Oct; 79(4):476-81. PubMed ID: 9389267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet inhibitory effect of nitroglycerin in platelet-rich plasma: relevance of glutathione-s-transferases in plasma.
    Chen LY; Mehta P; Mehta JL
    J Investig Med; 1996 Dec; 44(9):561-5. PubMed ID: 9035610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo.
    Takaoka A; Nakae I; Takahashi M; Matsumoto T; Liu Q; Mitsunami K; Kinoshita M
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):231-9. PubMed ID: 9475264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroglycerin-inhibited whole blood aggregation is partially mediated by calcitonin gene-related peptide -- a neurogenic mechanism.
    Booth BP; Nolan TD; Fung HL
    Br J Pharmacol; 1997 Oct; 122(3):577-83. PubMed ID: 9351518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet effects of nitroglycerin in healthy subjects and in patients with stable angina pectoris.
    Chirkov YY; Naujalis JI; Sage RE; Horowitz JD
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):384-9. PubMed ID: 7681498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained antiplatelet properties of nitroglycerin during hemodynamic tolerance in rats.
    Booth BP; Jacob S; Bauer JA; Fung HL
    J Cardiovasc Pharmacol; 1996 Sep; 28(3):432-8. PubMed ID: 8877591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
    Alarayyed NA; Cooper MB; Prichard BN; Betteridge DJ; Smith CC
    Br J Clin Pharmacol; 1997 Apr; 43(4):415-20. PubMed ID: 9146854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.
    Salvemini D; Pistelli A; Anggard E
    Br J Pharmacol; 1993 Nov; 110(3):937-42. PubMed ID: 8298817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasorelaxing effect of S-nitrosocaptopril on dog coronary arteries: no cross-tolerance with nitroglycerin.
    Matsumoto T; Takahashi M; Nakae I; Kinoshita M
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1247-53. PubMed ID: 8531088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
    Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.
    Crane MS; Rossi AG; Megson IL
    Br J Pharmacol; 2005 Mar; 144(6):849-59. PubMed ID: 15685209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrate resistance in platelets from patients with stable angina pectoris.
    Chirkov YY; Holmes AS; Chirkova LP; Horowitz JD
    Circulation; 1999 Jul; 100(2):129-34. PubMed ID: 10402441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extra-platelet low-molecular-mass thiols mediate the inhibitory action of S-nitrosoalbumin on human platelet aggregation via S-transnitrosylation of the platelet surface.
    Tsikas D
    Amino Acids; 2021 Apr; 53(4):563-573. PubMed ID: 33586042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel S-nitrosothiol causes prolonged and selective inhibition of platelet adhesion at sites of vascular injury.
    Miller MR; Hanspal IS; Hadoke PW; Newby DE; Rossi AG; Webb DJ; Megson IL
    Cardiovasc Res; 2003 Mar; 57(3):853-60. PubMed ID: 12618247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synergism of hydrogen peroxide with plasma S-nitrosothiols in the inhibition of platelet activation.
    Naseem KM; Chirico S; Mohammadi B; Bruckdorfer KR
    Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):759-66. PubMed ID: 8836116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.
    Megson IL; Sogo N; Mazzei FA; Butler AR; Walton JC; Webb DJ
    Br J Pharmacol; 2000 Dec; 131(7):1391-8. PubMed ID: 11090112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Acetylcysteine potentiates nitroglycerin-induced reversal of platelet aggregation.
    Chirkov YY; Horowitz JD
    J Cardiovasc Pharmacol; 1996 Sep; 28(3):375-80. PubMed ID: 8877583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of S-nitrosocaptopril on canine coronary circulation.
    Nakae I; Takahashi M; Kinoshita T; Matsumoto T; Kinoshita M
    J Pharmacol Exp Ther; 1995 Jul; 274(1):40-6. PubMed ID: 7616425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation.
    Donato JL; Marcondes S; Antunes E; Nogueira MD; Nader HB; Dietrich CP; Rendu F; de Nucci G
    Br J Pharmacol; 1996 Dec; 119(7):1447-53. PubMed ID: 8968554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.